In a regulatory filing, Lupin Ltd announced launch of Posaconazole delayed-release tablets, 100 mg, after its alliance partner AET Pharma US Inc. received an approval for its abbreviated new drug application from USFDA.
Copyright © 2024 | WordPress Theme by MH Themes
